Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Apoptosis-inducing effect of 6,7-dimethoxy-4-hydroxy-8-formylflavon from Nicotiana tabacum L leaf in human hepatoma HepG2 cells via activation of mitochondria-mediated apoptotic pathway

Qiu-Jie Zhang^1,2, Wen-Sheng Qiu¹, Hong-Xia Cui^1,2, Zhuang Yu¹, Ru-Yong Yao¹, Shi-Hai Liu¹, Zi-Min Liu¹, Jun Liang^1,3

¹Department of Medicine, Qingdao University, Qingdao 266003; ²Department of Oncology, Jining No. 1 People's Hospital, Jining 272011; ³Cancer Center, Peking University International Hospital, Beijing 102206, PR China.

For correspondence:- Jun Liang Email: junlianginqd@163.com

Accepted: 13 June 2018 Published: 28 July 2018

Citation: Zhang Q, Qiu W, Cui H, Yu Z, Yao R, Liu S, et al. Apoptosis-inducing effect of 6,7-dimethoxy-4-hydroxy-8-formylflavon from Nicotiana tabacum L leaf in human hepatoma HepG2 cells via activation of mitochondria-mediated apoptotic pathway. Trop J Pharm Res 2018; 17(7):1271-1277 doi: 10.4314/tjpr.v17i7.7

© 2018 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To study the anti-proliferative and apoptotic influences of 6,7-dimethoxy-4'-hydroxy-8-formylflavon (DHF) from the leaves of Nicotiana tabacum L. in human hepatoma HepG2 cells, and the underlying mechanisms.

Methods: The anti-proliferative effect of DHF (10 - 50 μg/mL) on HepG2 cells was assessed by CCK-8 assay. The pro-apoptotic effect of DHF (10, 20 and 30 μg/mL) on HepG2 cells was investigated via flow cytometry, while the mechanisms involved were studied using western blot. Xenograft assay was employed for determination of the in vivo effect of DHF (40 mg/kg/day) on HepG2 cell-induced tumor.

Results: The proliferation of HepG2 cells was inhibited by DHF (IC₅₀ = 25.87 μg/mL) due to apoptosis. In addition, xenograft assay revealed that HepG2 cell-induced tumor growth was significantly suppressed by DHF (p < 0.05 or 0.01) without any effects on mice body weights. The expressions of Survivin and Bcl-2 proteins were significantly decreased, while those of Bax, c-caspase-9, and c-caspase-3 proteins were significantly increased by DHF (p < 0.05 or 0.01), leading to increase in cytoplasmic levels of Smac and cytochrome c proteins.

Conclusion: The underlying mechanism DHF-mediated apoptotic changes in HepG2 cells in vitro and in vivo involves induction of the mitochondrial pathway of apoptosis. Thus, DHF is a good drug candidate for the development of an effective therapy for liver cancer.

Keywords: 6,7-Dimethoxy-4'-hydroxy-8-formylflavon, HepG2 cells, Hepatoma, Mitochondria, Apoptosis, Bax, Cytochrome C, Survivin